MORRISVILLE, N.C.--(BUSINESS WIRE)--Trimeris, Inc. (NASDAQ: TRMS) today announced financial results for the three months ended March 31, 2007, reporting total revenues of $17.4 million, an increase of 135 percent, compared to the same period last year. This increase was primarily influenced by the acceleration of milestone revenue and by strong global sales of FUZEON which reached $64.3 million, an increase of 16 percent over global sales of FUZEON in the same period last year. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd (“Roche”), Trimeris’ collaborative partner.
